Price$92.42-0.41 (-0.45%)
01:30 PM07:45 PM
News · 26 weeks80+18%
2025-10-262026-04-19
Mix5490d
- Insider41(76%)
- SEC Filings4(7%)
- Other3(6%)
- Earnings2(4%)
- Analyst2(4%)
- Dividends1(2%)
- Other1(2%)
Latest news
25 items- PRZimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial ResultsWARSAW, Ind., April 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its first quarter earnings conference call will be webcast on Tuesday, April 28, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET. A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.Individuals in the U.S. and Canada who wish to dial int
- PRZimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs OfficerExperienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacityWARSAW, Ind., April 7, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M. Vigdorchik, M.D., as Chief Science, Technology and Medical Affairs Officer, effective April 14. In this role, Dr. Vigdorchik will oversee the strategy, delivery, and management of the company's global end-to-end technology portfolio, including AI,
- INSIDERSEC Form 4 filed by Noor Jehanzeb4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Jafry Syed A.4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Kolli Sreelakshmi4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Shapiro Louis4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Hilado Maria Teresa4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Higgins Arthur J4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Kurdikar Devdatt4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Hagemann Robert4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Farrell Michael J.4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- SECSEC Form DEFA14A filed by Zimmer Biomet Holdings Inc.DEFA14A - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- SECSEC Form DEF 14A filed by Zimmer Biomet Holdings Inc.DEF 14A - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.SCHEDULE 13G/A - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Subject)
- ANALYSTZimmer Biomet downgraded by BTIG ResearchBTIG Research downgraded Zimmer Biomet from Buy to Neutral
- INSIDERSVP and CHRO Winkler Lori sold $250,849 worth of shares (2,650 units at $94.66), decreasing direct ownership by 21% to 10,224 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- SECSEC Form 144 filed by Zimmer Biomet Holdings Inc.144 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Subject)
- INSIDERExec VP, CFO Upadhyay Suketu covered exercise/tax liability with 6,576 shares and converted options into 14,776 shares, increasing direct ownership by 13% to 69,485 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERGroup Pres, EMEA Van Zuilen Wilfred converted options into 7,004 shares and covered exercise/tax liability with 1,822 shares, increasing direct ownership by 20% to 30,991 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSVP and CHRO Winkler Lori covered exercise/tax liability with 2,178 shares and converted options into 5,634 shares, increasing direct ownership by 37% to 12,874 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERGroup President, Asia Pacific Yi Sang converted options into 9,414 shares, increasing direct ownership by 41% to 32,251 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERVP, Controller, CAO Stellato Paul A converted options into 1,970 shares and covered exercise/tax liability with 915 shares, increasing direct ownership by 23% to 5,582 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDEROfficer Phipps Chad F converted options into 6,786 shares and covered exercise/tax liability with 2,732 shares, increasing direct ownership by 6% to 67,760 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERChairman, President and CEO Tornos Ivan converted options into 34,704 shares and covered exercise/tax liability with 19,195 shares, increasing direct ownership by 23% to 83,191 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERGroup Pres, EMEA Van Zuilen Wilfred converted options into 3,182 shares and covered exercise/tax liability with 828 shares, increasing direct ownership by 10% to 25,809 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)